- Home
- VRDN vs CAKE Comparison
VRDN vs CAKE Comparison
Compare VRDN & CAKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- CAKE
- Stock Information
- Founded
- VRDN 2006
- CAKE 1972
- Country
- VRDN United States
- CAKE United States
- Employees
- VRDN N/A
- CAKE N/A
- Industry
- VRDN Medical Specialities
- CAKE Restaurants
- Sector
- VRDN Health Care
- CAKE Consumer Discretionary
- Exchange
- VRDN Nasdaq
- CAKE Nasdaq
- Market Cap
- VRDN 2.7B
- CAKE 2.7B
- IPO Year
- VRDN N/A
- CAKE 1992
- Fundamental
- Price
- VRDN $30.44
- CAKE $45.23
- Analyst Decision
- VRDN Strong Buy
- CAKE Hold
- Analyst Count
- VRDN 11
- CAKE 15
- Target Price
- VRDN $39.60
- CAKE $57.87
- AVG Volume (30 Days)
- VRDN 1.8M
- CAKE 1.6M
- Earning Date
- VRDN 11-05-2025
- CAKE 10-28-2025
- Dividend Yield
- VRDN N/A
- CAKE 2.38%
- EPS Growth
- VRDN N/A
- CAKE 24.69
- EPS
- VRDN N/A
- CAKE 3.29
- Revenue
- VRDN $70,789,000.00
- CAKE $3,711,211,000.00
- Revenue This Year
- VRDN N/A
- CAKE $6.63
- Revenue Next Year
- VRDN $37,670.06
- CAKE $4.95
- P/E Ratio
- VRDN N/A
- CAKE $13.80
- Revenue Growth
- VRDN 23340.07
- CAKE 4.90
- 52 Week Low
- VRDN $9.90
- CAKE $42.69
- 52 Week High
- VRDN $30.77
- CAKE $69.70
- Technical
- Relative Strength Index (RSI)
- VRDN 77.12
- CAKE 36.19
- Support Level
- VRDN $28.33
- CAKE $43.07
- Resistance Level
- VRDN $29.58
- CAKE $45.41
- Average True Range (ATR)
- VRDN 1.32
- CAKE 1.36
- MACD
- VRDN 0.18
- CAKE -0.06
- Stochastic Oscillator
- VRDN 95.37
- CAKE 36.10
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About CAKE Cheesecake Factory Incorporated (The)
Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.